We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant.
Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced it has formed an agreement with the Texas Department of State Health Services (DSHS) to provide COVID-19...